Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-6 of 6 for your search:
Drug:
fowlpox virus vaccine vector
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase II Study of Recombinant Fowlpox Virus Encoding gp100 Peptide Preceded By an Endoplasmic Reticulum Insertion Signal in Patients With Metastatic Melanoma
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
16 and over
Sponsor:
NCI
Protocol IDs:
NCI-99-C-0044
, NCI-T98-0088, T99-0088, NCT00019669
2.
Phase II Randomized Study of Recombinant Fowlpox Prostate Specific Antigen Vaccine and Recombinant Vaccinia Prostate Specific Antigen Vaccine in Patients With Advanced Prostate Cancer (Summary Last Modified 11/2000)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
E-7897
, NCT00003871, E7897
3.
Phase II Randomized Study of Recombinant Fowlpox and Vaccinia Viruses Encoding Tyrosinase Antigen in Patients With Metastatic Melanoma
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
16 and over
Sponsor:
NCI
Protocol IDs:
NCI-99-C-0095
, NCI-T99-0025, T99-0025, NCT00019734
4.
Phase II Study of Lymphocyte-Depleting Nonmyeloablative Preparative Chemotherapy Comprising Fludarabine and Cyclophosphamide Followed By Autologous Lymphocyte Infusion, Recombinant Fowlpox Virus Encoding gp100 Peptide, and Aldesleukin in Patients With Recurrent or Refractory Metastatic Melanoma
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
16 and over
Sponsor:
NCI
Protocol IDs:
NCI-04-C-0152
, NCI-6585, 6585, NCT00084500
5.
Phase I Study of Immunization with Recombinant Fowlpox Virus Encoding the MART-1 Melanoma Antigen with or without Concomitant IL-2 in Patients with Metastatic Melanoma (Summary Last Modified 01/00)
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
over 18
Sponsor:
NCI
Protocol IDs:
NCI-95-C-0032D
, NCI-T96-0026N, T96-0026
6.
Phase I Study of Immunization With a Recombinant Fowlpox Virus Encoding the gp100 Melanoma Antigen With or Without Concurrent Interleukin-2 in Patients With Recurrent Metastatic Melanoma (Summary Last Modified 04/2002)
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NCI-96-C-0121
, NCI-T94-0139N, T94-0139, NCT00019175
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute